Sun Pharma Enters Anti-fungal Powder OTC Category
Sun Pharma Consumer Healthcare (CHC), a division of Sun Pharmaceutical Industries Ltd., has announced its entry into the anti-fungal powder OTC category with Abzorb. The brand will be co-promoted across prescription & OTC channels in India to drive growth and the company has launched a 360° marketing campaign comprising TV, print & digital to expand consumer outreach.
According to a company press release, Abzorb’s unique combination of talc & starch ensures superior sweat absorption, and clotrimazole, one of the best-in-class anti-fungal, helps treat infection & prevents its recurrence. The new packaging design, with an angular dispensing nozzle, enhances consumer experience through targeted application. The new pack makes it easier to apply the product on difficult to reach areas thereby reducing wastage. The product is available in 100 g & 50 g packaging.
According to Vidhi Salgaocar, Head, Consumer Healthcare, Sun Pharma, fungal infections are a common occurrence and are often left untreated because of the associated social stigma. “The intent of the 360° marketing campaign is to raise consumer awareness regarding fungal infections and empower them to treat the infection and lead a healthier life.”
2026-08-22
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Strong demand is urgently needed. Blue Ocean Value highlights OTC hearing aid market.
-
Bayer Showcases the Latest Progress in the R&D Pipeline of Prescription Drugs, Promotes Medical Innovation and Facilitates Business Transformation
-
A Pilot Sale of Class B OTC Drugs in 58 Convenience Stores in Beijing
-
Shin-Etsu Chemical Invests $218 Million in Rare Earth Refinery as Multiple Countries Accelerate Domestic Production
-
Givaudan Introduces New Labdanum Absolute for Fragrance Creations
-
Henkel’s €60 Million Adhesive Technologies Inspiration Center in Shanghai Goes into Operation, Aiming to Build an R&D Hub for Asia-Pacific
-
Marinela Makeup Partners with FasterCapital to Scale Its Vegan Beauty Line
-
BASF to Shut Down Hydrosulfites Production in Ludwigshafen
-
Dow × Hisense’s Innovation Code: A Deep Game of Sustainability
-
Pregabalin vs Gabapentin: Differences, Uses, and Side Effects
Recommend Reading
-
Lotte Merges with HD Hyundai: Can Korea’s Petrochemical First Case Trigger True Restructuring?
-
Syngenta Bee Pesticide Protest Shows the Pressure Building Around Crop Protection Giants
-
BASF's Zhanjiang Plant Steam Cracking Unit Commences Operation
-
Overseas Up, China Down: The Global MDI Market Is Splitting Apart
-
Yulong Petrochemical’s 100,000-ton MMA Project Comes Online Amid a “Deep V-Shaped Rebound” — Opportunity or Hidden Risk?
-
A Strong Wait-and-See Atmosphere Leads to a Slight Weakening in the Acrylic Market
-
Insufficient Demand for Cyclohexane in China, Prices Narrowly Fluctuate
-
2026 Week 19 Commodity Weekly Report: Chemicals Lead Decline, Energy and Non-ferrous Metals Show Strength in Some Areas
-
Ethyl Acetate Market Prices Adjusted and Risen
-
Crude Oil Prices First Fall, Then Rise; Retail Prices for Refined Oil Products Raised Again in This Round